| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| PPAR alpha | 13 | 2023 | 21 | 6.780 |
Why?
|
| Mice | 53 | 2023 | 760 | 5.080 |
Why?
|
| Animals | 66 | 2023 | 2092 | 4.770 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 13 | 2023 | 27 | 4.750 |
Why?
|
| Astrocytes | 17 | 2021 | 70 | 4.440 |
Why?
|
| Up-Regulation | 15 | 2023 | 89 | 4.210 |
Why?
|
| Gemfibrozil | 12 | 2023 | 20 | 4.150 |
Why?
|
| Neurons | 14 | 2020 | 164 | 3.840 |
Why?
|
| Microglia | 16 | 2023 | 64 | 3.460 |
Why?
|
| Dopaminergic Neurons | 7 | 2023 | 23 | 3.450 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 8 | 2019 | 46 | 3.150 |
Why?
|
| Aspirin | 5 | 2019 | 20 | 2.820 |
Why?
|
| Multiple Sclerosis | 7 | 2023 | 32 | 2.440 |
Why?
|
| Parkinsonian Disorders | 6 | 2021 | 91 | 2.440 |
Why?
|
| Neuronal Ceroid-Lipofuscinoses | 5 | 2023 | 6 | 2.290 |
Why?
|
| Interleukin-12 Subunit p40 | 6 | 2020 | 11 | 2.100 |
Why?
|
| Sodium Benzoate | 6 | 2019 | 8 | 2.050 |
Why?
|
| Signal Transduction | 14 | 2021 | 246 | 2.010 |
Why?
|
| Cells, Cultured | 28 | 2021 | 275 | 1.970 |
Why?
|
| Substantia Nigra | 6 | 2022 | 68 | 1.940 |
Why?
|
| Disease Models, Animal | 17 | 2023 | 338 | 1.880 |
Why?
|
| Cinnamomum zeylanicum | 6 | 2019 | 9 | 1.800 |
Why?
|
| Alzheimer Disease | 8 | 2023 | 800 | 1.750 |
Why?
|
| NF-kappa B | 14 | 2023 | 53 | 1.740 |
Why?
|
| Mice, Inbred C57BL | 14 | 2023 | 205 | 1.630 |
Why?
|
| Hypolipidemic Agents | 5 | 2017 | 10 | 1.610 |
Why?
|
| Gene Expression Regulation | 9 | 2019 | 125 | 1.490 |
Why?
|
| Sodium Chloride | 4 | 2017 | 16 | 1.480 |
Why?
|
| Neuroprotective Agents | 4 | 2021 | 24 | 1.480 |
Why?
|
| Peptides | 3 | 2021 | 42 | 1.470 |
Why?
|
| Parkinson Disease | 6 | 2023 | 314 | 1.410 |
Why?
|
| alpha-Synuclein | 2 | 2022 | 59 | 1.350 |
Why?
|
| Humans | 42 | 2023 | 12240 | 1.320 |
Why?
|
| Receptors, Interleukin-12 | 4 | 2020 | 8 | 1.310 |
Why?
|
| Neuroglia | 6 | 2023 | 19 | 1.270 |
Why?
|
| PPAR-beta | 3 | 2023 | 8 | 1.260 |
Why?
|
| Suppressor of Cytokine Signaling 3 Protein | 3 | 2019 | 4 | 1.260 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 2 | 2021 | 14 | 1.250 |
Why?
|
| Interleukin-12 | 5 | 2020 | 17 | 1.240 |
Why?
|
| Adoptive Transfer | 4 | 2017 | 18 | 1.240 |
Why?
|
| Plaque, Amyloid | 3 | 2019 | 45 | 1.210 |
Why?
|
| T-Lymphocytes, Regulatory | 5 | 2019 | 16 | 1.190 |
Why?
|
| Brain | 10 | 2021 | 707 | 1.190 |
Why?
|
| Cytokines | 11 | 2023 | 107 | 1.160 |
Why?
|
| Corpus Striatum | 2 | 2019 | 42 | 1.140 |
Why?
|
| Cinnamates | 2 | 2019 | 4 | 1.110 |
Why?
|
| Hippocampus | 3 | 2020 | 97 | 1.100 |
Why?
|
| Aminopeptidases | 3 | 2019 | 3 | 1.090 |
Why?
|
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 3 | 2019 | 3 | 1.090 |
Why?
|
| Serine Proteases | 3 | 2019 | 4 | 1.090 |
Why?
|
| Nitric Oxide Synthase | 8 | 2004 | 21 | 1.060 |
Why?
|
| Apoptosis | 7 | 2017 | 105 | 1.040 |
Why?
|
| Myelin Basic Protein | 7 | 2013 | 12 | 1.010 |
Why?
|
| Nitric Oxide Synthase Type II | 12 | 2014 | 26 | 0.980 |
Why?
|
| Protein Deglycase DJ-1 | 3 | 2023 | 4 | 0.960 |
Why?
|
| Nitric Oxide | 8 | 2014 | 36 | 0.930 |
Why?
|
| Chemokine CCL5 | 2 | 2016 | 4 | 0.920 |
Why?
|
| Oligodendroglia | 3 | 2015 | 12 | 0.900 |
Why?
|
| Inflammation Mediators | 7 | 2021 | 37 | 0.900 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2020 | 19 | 0.890 |
Why?
|
| Lysosomes | 4 | 2018 | 13 | 0.890 |
Why?
|
| Spike Glycoprotein, Coronavirus | 2 | 2021 | 11 | 0.870 |
Why?
|
| Mice, Knockout | 8 | 2021 | 170 | 0.870 |
Why?
|
| Memory | 2 | 2015 | 112 | 0.840 |
Why?
|
| MPTP Poisoning | 3 | 2019 | 6 | 0.830 |
Why?
|
| Ascorbic Acid | 1 | 2023 | 25 | 0.780 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2015 | 22 | 0.770 |
Why?
|
| Oncogene Proteins | 2 | 2014 | 3 | 0.760 |
Why?
|
| Immunosuppressive Agents | 2 | 2019 | 61 | 0.760 |
Why?
|
| Female | 17 | 2021 | 6974 | 0.750 |
Why?
|
| Physical Conditioning, Animal | 1 | 2022 | 1 | 0.740 |
Why?
|
| Food Preservatives | 2 | 2015 | 4 | 0.720 |
Why?
|
| Syzygium | 1 | 2021 | 2 | 0.700 |
Why?
|
| T-Lymphocytes | 5 | 2010 | 50 | 0.700 |
Why?
|
| Sphingomyelin Phosphodiesterase | 3 | 2010 | 6 | 0.690 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2021 | 39 | 0.680 |
Why?
|
| Organelle Biogenesis | 2 | 2018 | 3 | 0.670 |
Why?
|
| Lung | 1 | 2021 | 76 | 0.670 |
Why?
|
| Palmitic Acids | 1 | 2020 | 1 | 0.640 |
Why?
|
| Protein Binding | 5 | 2021 | 70 | 0.630 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 5 | 2019 | 13 | 0.620 |
Why?
|
| Mice, Transgenic | 6 | 2023 | 97 | 0.610 |
Why?
|
| Interferon-gamma | 4 | 2017 | 26 | 0.610 |
Why?
|
| Forkhead Transcription Factors | 2 | 2010 | 6 | 0.610 |
Why?
|
| Oxidative Stress | 4 | 2023 | 53 | 0.610 |
Why?
|
| Mitochondria | 3 | 2017 | 34 | 0.600 |
Why?
|
| tau Proteins | 2 | 2023 | 88 | 0.600 |
Why?
|
| Chemokine CCL11 | 2 | 2016 | 4 | 0.590 |
Why?
|
| Antiparkinson Agents | 1 | 2019 | 18 | 0.590 |
Why?
|
| Butyrates | 1 | 2019 | 7 | 0.580 |
Why?
|
| Male | 11 | 2021 | 6815 | 0.580 |
Why?
|
| Cell Line | 9 | 2019 | 150 | 0.570 |
Why?
|
| Interleukin-11 | 1 | 2018 | 5 | 0.570 |
Why?
|
| Myelin Sheath | 3 | 2015 | 11 | 0.560 |
Why?
|
| Neuronal Plasticity | 2 | 2018 | 27 | 0.550 |
Why?
|
| HEK293 Cells | 3 | 2023 | 20 | 0.550 |
Why?
|
| Peptide Fragments | 3 | 2018 | 27 | 0.540 |
Why?
|
| Pharmaceutical Solutions | 1 | 2017 | 1 | 0.540 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2016 | 54 | 0.530 |
Why?
|
| Promoter Regions, Genetic | 5 | 2021 | 40 | 0.520 |
Why?
|
| Down-Regulation | 3 | 2014 | 46 | 0.510 |
Why?
|
| Prostatic Neoplasms | 1 | 2017 | 36 | 0.510 |
Why?
|
| Longevity | 1 | 2017 | 15 | 0.510 |
Why?
|
| Tumor Necrosis Factor-alpha | 6 | 2014 | 95 | 0.510 |
Why?
|
| Primary Cell Culture | 4 | 2021 | 19 | 0.500 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2017 | 23 | 0.500 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 2 | 2017 | 9 | 0.490 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2017 | 16 | 0.490 |
Why?
|
| Macrophages, Peritoneal | 5 | 2008 | 7 | 0.480 |
Why?
|
| Amyloid beta-Peptides | 3 | 2014 | 98 | 0.480 |
Why?
|
| HIV Envelope Protein gp120 | 2 | 2007 | 8 | 0.470 |
Why?
|
| Ciliary Neurotrophic Factor | 1 | 2015 | 7 | 0.460 |
Why?
|
| Nerve Tissue Proteins | 2 | 2014 | 87 | 0.460 |
Why?
|
| Simvastatin | 1 | 2015 | 7 | 0.450 |
Why?
|
| Nerve Growth Factors | 1 | 2015 | 17 | 0.440 |
Why?
|
| Dose-Response Relationship, Drug | 7 | 2018 | 179 | 0.440 |
Why?
|
| Plant Extracts | 1 | 2015 | 6 | 0.440 |
Why?
|
| Th17 Cells | 4 | 2020 | 15 | 0.440 |
Why?
|
| Antioxidants | 2 | 2012 | 34 | 0.420 |
Why?
|
| Lipopolysaccharides | 8 | 2018 | 41 | 0.420 |
Why?
|
| Cerebral Cortex | 3 | 2012 | 77 | 0.420 |
Why?
|
| Synaptic Transmission | 1 | 2014 | 14 | 0.420 |
Why?
|
| Cinnamomum | 1 | 2014 | 1 | 0.420 |
Why?
|
| Peroxiredoxins | 1 | 2014 | 9 | 0.420 |
Why?
|
| Phytotherapy | 1 | 2014 | 8 | 0.420 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2014 | 15 | 0.420 |
Why?
|
| Enzyme Activation | 6 | 2015 | 64 | 0.420 |
Why?
|
| Phenylbutyrates | 2 | 2012 | 3 | 0.420 |
Why?
|
| Oxygen | 1 | 2014 | 26 | 0.420 |
Why?
|
| Enzyme Inhibitors | 6 | 2004 | 75 | 0.420 |
Why?
|
| RNA, Messenger | 7 | 2018 | 157 | 0.410 |
Why?
|
| Superoxide Dismutase | 3 | 2007 | 11 | 0.410 |
Why?
|
| Cell Movement | 3 | 2009 | 42 | 0.390 |
Why?
|
| Food Additives | 2 | 2011 | 3 | 0.390 |
Why?
|
| Administration, Oral | 4 | 2020 | 55 | 0.380 |
Why?
|
| Myeloid Differentiation Factor 88 | 2 | 2023 | 5 | 0.370 |
Why?
|
| Fenofibrate | 1 | 2012 | 2 | 0.370 |
Why?
|
| Toll-Like Receptor 2 | 2 | 2023 | 13 | 0.370 |
Why?
|
| Protein Multimerization | 2 | 2009 | 7 | 0.370 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2010 | 18 | 0.360 |
Why?
|
| Neurodegenerative Diseases | 1 | 2012 | 60 | 0.340 |
Why?
|
| Th2 Cells | 2 | 2010 | 9 | 0.340 |
Why?
|
| Transcription Factors | 4 | 2019 | 105 | 0.330 |
Why?
|
| Sphingolipids | 1 | 2010 | 3 | 0.320 |
Why?
|
| Microbodies | 5 | 1998 | 5 | 0.320 |
Why?
|
| Inflammation | 3 | 2023 | 124 | 0.310 |
Why?
|
| Motor Activity | 3 | 2017 | 175 | 0.290 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2009 | 1 | 0.290 |
Why?
|
| Cell Communication | 1 | 2009 | 14 | 0.290 |
Why?
|
| Lymphotoxin-alpha | 1 | 2008 | 2 | 0.290 |
Why?
|
| Interleukin-12 Receptor beta 1 Subunit | 1 | 2008 | 2 | 0.290 |
Why?
|
| Antibodies, Monoclonal | 1 | 2009 | 86 | 0.280 |
Why?
|
| RNA, Double-Stranded | 2 | 2007 | 3 | 0.270 |
Why?
|
| Rats | 7 | 2010 | 407 | 0.270 |
Why?
|
| RNA, Small Interfering | 3 | 2018 | 45 | 0.270 |
Why?
|
| Phytanic Acid | 4 | 1996 | 4 | 0.260 |
Why?
|
| Neurotrophin 3 | 1 | 2007 | 1 | 0.260 |
Why?
|
| Integrins | 1 | 2007 | 8 | 0.260 |
Why?
|
| I-kappa B Proteins | 1 | 2007 | 6 | 0.260 |
Why?
|
| Genes, Dominant | 3 | 2005 | 6 | 0.260 |
Why?
|
| Mice, Inbred Strains | 4 | 2010 | 15 | 0.260 |
Why?
|
| Mutation | 3 | 2021 | 175 | 0.260 |
Why?
|
| Plant Bark | 2 | 2019 | 2 | 0.250 |
Why?
|
| Mevalonic Acid | 3 | 2012 | 3 | 0.250 |
Why?
|
| AIDS Dementia Complex | 1 | 2007 | 31 | 0.250 |
Why?
|
| Th1 Cells | 3 | 2018 | 10 | 0.250 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 2 | 2017 | 5 | 0.240 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2011 | 68 | 0.240 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2000 | 19 | 0.230 |
Why?
|
| Transfection | 3 | 2018 | 59 | 0.230 |
Why?
|
| eIF-2 Kinase | 1 | 2004 | 1 | 0.210 |
Why?
|
| Retinoid X Receptor alpha | 2 | 2015 | 5 | 0.200 |
Why?
|
| PPAR gamma | 2 | 2015 | 9 | 0.200 |
Why?
|
| Demyelinating Diseases | 2 | 2015 | 7 | 0.200 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 4 | 2005 | 6 | 0.200 |
Why?
|
| Macaca mulatta | 2 | 2015 | 25 | 0.200 |
Why?
|
| Disease Progression | 3 | 2012 | 290 | 0.200 |
Why?
|
| Valerates | 1 | 2023 | 2 | 0.200 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2023 | 28 | 0.200 |
Why?
|
| Protein Subunits | 1 | 2003 | 8 | 0.200 |
Why?
|
| Virus Internalization | 1 | 2023 | 7 | 0.200 |
Why?
|
| Fruit | 1 | 2023 | 18 | 0.200 |
Why?
|
| HIV-1 | 1 | 2004 | 143 | 0.190 |
Why?
|
| Phenylacetates | 1 | 2003 | 2 | 0.190 |
Why?
|
| Tyrosine | 1 | 2003 | 10 | 0.190 |
Why?
|
| Molecular Chaperones | 1 | 2023 | 8 | 0.190 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2014 | 35 | 0.190 |
Why?
|
| Membrane Glycoproteins | 1 | 2023 | 30 | 0.190 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 3 | 2009 | 27 | 0.180 |
Why?
|
| Ocimum sanctum | 1 | 2021 | 2 | 0.180 |
Why?
|
| Eugenol | 1 | 2021 | 2 | 0.180 |
Why?
|
| Spices | 1 | 2021 | 2 | 0.180 |
Why?
|
| A549 Cells | 1 | 2021 | 5 | 0.180 |
Why?
|
| Locomotion | 1 | 2021 | 8 | 0.180 |
Why?
|
| CD40 Antigens | 1 | 2001 | 3 | 0.170 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2021 | 12 | 0.170 |
Why?
|
| Molecular Targeted Therapy | 1 | 2021 | 16 | 0.170 |
Why?
|
| Ceramides | 3 | 2010 | 6 | 0.170 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 2152 | 0.170 |
Why?
|
| Multiple System Atrophy | 1 | 2021 | 22 | 0.170 |
Why?
|
| Cytochrome P-450 CYP2C8 Inhibitors | 1 | 2021 | 2 | 0.170 |
Why?
|
| Lewy Body Disease | 1 | 2021 | 54 | 0.170 |
Why?
|
| Immunoblotting | 3 | 2007 | 29 | 0.160 |
Why?
|
| Interleukin-23 | 1 | 2020 | 3 | 0.160 |
Why?
|
| Recombinant Proteins | 1 | 2020 | 90 | 0.160 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2000 | 9 | 0.160 |
Why?
|
| Enzyme Induction | 4 | 2004 | 9 | 0.160 |
Why?
|
| Spinal Cord | 2 | 2015 | 46 | 0.150 |
Why?
|
| Mercury | 3 | 1995 | 3 | 0.150 |
Why?
|
| Sphingosine | 1 | 1999 | 2 | 0.150 |
Why?
|
| Pars Compacta | 1 | 2019 | 1 | 0.150 |
Why?
|
| Biotransformation | 1 | 2019 | 4 | 0.150 |
Why?
|
| Rotarod Performance Test | 1 | 2019 | 4 | 0.150 |
Why?
|
| Exploratory Behavior | 1 | 2019 | 6 | 0.150 |
Why?
|
| Interleukins | 1 | 2019 | 13 | 0.150 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2019 | 18 | 0.150 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2015 | 28 | 0.150 |
Why?
|
| Refsum Disease | 2 | 1996 | 2 | 0.150 |
Why?
|
| Protein Structure, Secondary | 1 | 2019 | 16 | 0.140 |
Why?
|
| Rotenone | 1 | 2018 | 5 | 0.140 |
Why?
|
| Reactive Oxygen Species | 2 | 2012 | 55 | 0.140 |
Why?
|
| Oxidoreductases | 3 | 1997 | 4 | 0.140 |
Why?
|
| Gastrointestinal Diseases | 1 | 2018 | 14 | 0.140 |
Why?
|
| Middle Aged | 2 | 2017 | 4043 | 0.140 |
Why?
|
| Aged | 2 | 2017 | 4000 | 0.140 |
Why?
|
| Channelopathies | 1 | 2018 | 5 | 0.140 |
Why?
|
| Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels | 1 | 2018 | 5 | 0.140 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2016 | 61 | 0.140 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2018 | 8 | 0.140 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 1998 | 4 | 0.140 |
Why?
|
| Isoenzymes | 1 | 1998 | 28 | 0.140 |
Why?
|
| Phosphorylation | 2 | 2014 | 78 | 0.140 |
Why?
|
| Pyramidal Cells | 1 | 2018 | 28 | 0.140 |
Why?
|
| CREB-Binding Protein | 1 | 2018 | 2 | 0.140 |
Why?
|
| Mass Spectrometry | 1 | 2018 | 16 | 0.130 |
Why?
|
| Interleukin-1 | 3 | 2005 | 23 | 0.130 |
Why?
|
| Neoplasms, Experimental | 1 | 2017 | 4 | 0.130 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2018 | 74 | 0.130 |
Why?
|
| Prostate | 1 | 2017 | 15 | 0.130 |
Why?
|
| Oxidation-Reduction | 6 | 2004 | 33 | 0.130 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 60 | 0.130 |
Why?
|
| bcl-Associated Death Protein | 1 | 2017 | 1 | 0.130 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 128 | 0.130 |
Why?
|
| Cyclic AMP | 1 | 1997 | 17 | 0.130 |
Why?
|
| Cell Differentiation | 2 | 2010 | 73 | 0.130 |
Why?
|
| Antibodies, Blocking | 1 | 2016 | 2 | 0.120 |
Why?
|
| Adaptive Immunity | 1 | 2016 | 4 | 0.120 |
Why?
|
| Chondrodysplasia Punctata, Rhizomelic | 1 | 1996 | 1 | 0.120 |
Why?
|
| Macrophages | 2 | 2010 | 38 | 0.120 |
Why?
|
| Coenzyme A Ligases | 2 | 1995 | 2 | 0.120 |
Why?
|
| Poly I-C | 2 | 2007 | 5 | 0.120 |
Why?
|
| Superoxides | 2 | 2007 | 9 | 0.120 |
Why?
|
| Isoquinolines | 1 | 2015 | 10 | 0.120 |
Why?
|
| DNA, Complementary | 2 | 2008 | 16 | 0.120 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 26 | 0.110 |
Why?
|
| Sulfonamides | 1 | 2015 | 22 | 0.110 |
Why?
|
| Growth Inhibitors | 2 | 2007 | 6 | 0.110 |
Why?
|
| Mice, Mutant Strains | 1 | 2015 | 15 | 0.110 |
Why?
|
| Intracellular Membranes | 1 | 1995 | 13 | 0.110 |
Why?
|
| CCAAT-Binding Factor | 1 | 2015 | 2 | 0.110 |
Why?
|
| Tretinoin | 1 | 2015 | 8 | 0.110 |
Why?
|
| Microfilament Proteins | 1 | 2015 | 15 | 0.110 |
Why?
|
| Calcium-Binding Proteins | 1 | 2015 | 17 | 0.110 |
Why?
|
| Antigens, CD | 1 | 2015 | 28 | 0.110 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2015 | 28 | 0.110 |
Why?
|
| Lipid Metabolism | 1 | 2015 | 23 | 0.110 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2015 | 11 | 0.110 |
Why?
|
| Child | 1 | 2017 | 614 | 0.110 |
Why?
|
| Myelin Proteolipid Protein | 1 | 2015 | 2 | 0.110 |
Why?
|
| Autophagy | 1 | 2015 | 16 | 0.110 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2015 | 11 | 0.110 |
Why?
|
| Blood-Brain Barrier | 1 | 2015 | 18 | 0.110 |
Why?
|
| Spatial Learning | 1 | 2014 | 2 | 0.110 |
Why?
|
| Amyloid | 1 | 2014 | 20 | 0.110 |
Why?
|
| Powders | 1 | 2014 | 1 | 0.110 |
Why?
|
| Class Ia Phosphatidylinositol 3-Kinase | 1 | 2014 | 3 | 0.110 |
Why?
|
| Interleukin-1beta | 1 | 2014 | 17 | 0.110 |
Why?
|
| Cell Death | 2 | 2013 | 22 | 0.100 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2014 | 30 | 0.100 |
Why?
|
| Bacillus | 1 | 1994 | 1 | 0.100 |
Why?
|
| Lyases | 1 | 1994 | 4 | 0.100 |
Why?
|
| Fetus | 2 | 2007 | 20 | 0.100 |
Why?
|
| DNA-Binding Proteins | 1 | 2015 | 151 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2004 | 23 | 0.100 |
Why?
|
| Incidence | 1 | 2015 | 338 | 0.100 |
Why?
|
| Severity of Illness Index | 2 | 2007 | 423 | 0.100 |
Why?
|
| Transcription, Genetic | 2 | 2005 | 53 | 0.100 |
Why?
|
| Axons | 1 | 2013 | 10 | 0.100 |
Why?
|
| Microtubules | 1 | 2013 | 18 | 0.100 |
Why?
|
| Genes, Reporter | 2 | 2004 | 15 | 0.100 |
Why?
|
| Lymphocytes | 1 | 2013 | 30 | 0.090 |
Why?
|
| Adult | 1 | 2020 | 3557 | 0.090 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2012 | 27 | 0.090 |
Why?
|
| Response Elements | 1 | 2012 | 5 | 0.090 |
Why?
|
| Oncogene Protein p21(ras) | 1 | 2012 | 1 | 0.090 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2012 | 3 | 0.090 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2012 | 2 | 0.090 |
Why?
|
| I-kappa B Kinase | 1 | 2012 | 5 | 0.090 |
Why?
|
| Transcription Factor RelA | 2 | 2003 | 9 | 0.090 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 80 | 0.090 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 100 | 0.090 |
Why?
|
| Fibroblasts | 5 | 1999 | 24 | 0.090 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2013 | 8 | 0.090 |
Why?
|
| Calcium | 1 | 2014 | 288 | 0.090 |
Why?
|
| Alkyl and Aryl Transferases | 1 | 2011 | 1 | 0.090 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2011 | 15 | 0.090 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2011 | 28 | 0.080 |
Why?
|
| Time Factors | 2 | 2004 | 695 | 0.080 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2010 | 4 | 0.080 |
Why?
|
| Coculture Techniques | 1 | 2010 | 18 | 0.080 |
Why?
|
| Blotting, Northern | 2 | 2001 | 13 | 0.080 |
Why?
|
| Gliosis | 1 | 2010 | 6 | 0.080 |
Why?
|
| Genes, T-Cell Receptor | 1 | 2010 | 1 | 0.080 |
Why?
|
| Interleukin-17 | 1 | 2010 | 6 | 0.080 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 171 | 0.080 |
Why?
|
| Myelin-Oligodendrocyte Glycoprotein | 1 | 2010 | 2 | 0.080 |
Why?
|
| Cattle | 1 | 2010 | 54 | 0.080 |
Why?
|
| Cricetulus | 1 | 2009 | 10 | 0.080 |
Why?
|
| Glycoproteins | 1 | 2010 | 30 | 0.080 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 16 | 0.080 |
Why?
|
| CHO Cells | 1 | 2009 | 6 | 0.080 |
Why?
|
| Cricetinae | 1 | 2009 | 19 | 0.080 |
Why?
|
| Serum Albumin | 1 | 2009 | 13 | 0.080 |
Why?
|
| MAP Kinase Signaling System | 1 | 2009 | 22 | 0.080 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2009 | 7 | 0.070 |
Why?
|
| Spleen | 1 | 2009 | 15 | 0.070 |
Why?
|
| Antigen Presentation | 1 | 2009 | 5 | 0.070 |
Why?
|
| Hyperlipidemias | 1 | 2009 | 8 | 0.070 |
Why?
|
| Triglycerides | 1 | 2009 | 24 | 0.070 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2008 | 2 | 0.070 |
Why?
|
| Biological Transport | 3 | 1998 | 23 | 0.070 |
Why?
|
| Prions | 1 | 2007 | 2 | 0.070 |
Why?
|
| Androstadienes | 1 | 2007 | 3 | 0.070 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2007 | 4 | 0.070 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2007 | 3 | 0.070 |
Why?
|
| Cell Separation | 1 | 2007 | 10 | 0.070 |
Why?
|
| Immunologic Factors | 1 | 2007 | 6 | 0.070 |
Why?
|
| Injections, Subcutaneous | 1 | 2007 | 12 | 0.070 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2007 | 11 | 0.060 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2007 | 6 | 0.060 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2007 | 28 | 0.060 |
Why?
|
| Catalase | 2 | 1998 | 3 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2007 | 225 | 0.060 |
Why?
|
| Pregnancy | 1 | 2007 | 193 | 0.060 |
Why?
|
| Castration | 1 | 2005 | 2 | 0.060 |
Why?
|
| RNA | 1 | 2005 | 18 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 33 | 0.060 |
Why?
|
| Cell Nucleus | 1 | 2005 | 42 | 0.060 |
Why?
|
| Central Nervous System | 1 | 2005 | 29 | 0.060 |
Why?
|
| Interleukin-6 | 1 | 2005 | 48 | 0.060 |
Why?
|
| Cell Membrane | 1 | 2005 | 63 | 0.060 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 2 | 2002 | 15 | 0.060 |
Why?
|
| Gene Products, tat | 1 | 2004 | 2 | 0.050 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 1 | 2004 | 4 | 0.050 |
Why?
|
| Receptors, CXCR4 | 1 | 2004 | 15 | 0.050 |
Why?
|
| Sex Factors | 1 | 2005 | 229 | 0.050 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 1 | 2004 | 10 | 0.050 |
Why?
|
| NADPH Oxidases | 1 | 2004 | 24 | 0.050 |
Why?
|
| In Vitro Techniques | 1 | 2004 | 117 | 0.050 |
Why?
|
| Luciferases | 1 | 2004 | 9 | 0.050 |
Why?
|
| Transcriptional Activation | 1 | 2004 | 13 | 0.050 |
Why?
|
| Dimerization | 1 | 2003 | 8 | 0.050 |
Why?
|
| Injections, Intraperitoneal | 1 | 2003 | 4 | 0.050 |
Why?
|
| Lymphocyte Activation | 1 | 2003 | 39 | 0.050 |
Why?
|
| Acute Disease | 1 | 2003 | 90 | 0.050 |
Why?
|
| Blotting, Western | 1 | 2002 | 62 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2003 | 186 | 0.050 |
Why?
|
| Ligands | 1 | 2001 | 23 | 0.040 |
Why?
|
| DNA | 1 | 2001 | 57 | 0.040 |
Why?
|
| Skin | 2 | 1999 | 73 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 2 | 2018 | 13 | 0.040 |
Why?
|
| Neuritis | 1 | 2000 | 1 | 0.040 |
Why?
|
| Lysosomal Storage Diseases | 1 | 1999 | 1 | 0.040 |
Why?
|
| Antisense Elements (Genetics) | 1 | 1999 | 2 | 0.040 |
Why?
|
| Glomerular Mesangium | 1 | 1999 | 2 | 0.040 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1998 | 1 | 0.030 |
Why?
|
| Okadaic Acid | 1 | 1998 | 2 | 0.030 |
Why?
|
| Protein Phosphatase 1 | 1 | 1998 | 2 | 0.030 |
Why?
|
| Peroxisomal Disorders | 1 | 1998 | 1 | 0.030 |
Why?
|
| Action Potentials | 1 | 2018 | 64 | 0.030 |
Why?
|
| Nervous System Diseases | 1 | 1998 | 60 | 0.030 |
Why?
|
| Colforsin | 1 | 1997 | 8 | 0.030 |
Why?
|
| Catalysis | 1 | 1997 | 9 | 0.030 |
Why?
|
| Coenzyme A | 1 | 1996 | 1 | 0.030 |
Why?
|
| Hydroxylation | 1 | 1996 | 1 | 0.030 |
Why?
|
| Reference Values | 1 | 1996 | 103 | 0.030 |
Why?
|
| Arginine | 1 | 1995 | 2 | 0.030 |
Why?
|
| Nitroprusside | 1 | 1995 | 6 | 0.030 |
Why?
|
| Organomercury Compounds | 1 | 1995 | 1 | 0.030 |
Why?
|
| Dextrans | 1 | 1995 | 2 | 0.030 |
Why?
|
| Binding Sites | 1 | 1995 | 39 | 0.030 |
Why?
|
| Liver | 1 | 1995 | 57 | 0.030 |
Why?
|
| Drug Resistance, Microbial | 1 | 1994 | 29 | 0.030 |
Why?
|
| Perforin | 1 | 2013 | 2 | 0.020 |
Why?
|
| Granzymes | 1 | 2013 | 6 | 0.020 |
Why?
|
| Luminescent Proteins | 1 | 2013 | 2 | 0.020 |
Why?
|
| Culture Media, Conditioned | 1 | 2013 | 9 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2013 | 12 | 0.020 |
Why?
|
| Aging | 1 | 2018 | 680 | 0.020 |
Why?
|
| Killer Cells, Natural | 1 | 2013 | 21 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2013 | 51 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2013 | 48 | 0.020 |
Why?
|
| Models, Biological | 1 | 2013 | 191 | 0.020 |
Why?
|
| Fatty Acids | 3 | 1998 | 20 | 0.020 |
Why?
|
| Glutathione | 1 | 1991 | 18 | 0.020 |
Why?
|
| Bacteria | 1 | 1991 | 34 | 0.020 |
Why?
|
| Penicillamine | 2 | 1997 | 2 | 0.020 |
Why?
|
| S-Nitroso-N-Acetylpenicillamine | 2 | 1997 | 2 | 0.020 |
Why?
|
| Peroxisome-Targeting Signal 1 Receptor | 1 | 1998 | 1 | 0.010 |
Why?
|
| Peroxisomal Targeting Signal 2 Receptor | 1 | 1998 | 1 | 0.010 |
Why?
|
| Plasmalogens | 1 | 1998 | 1 | 0.010 |
Why?
|
| Zellweger Syndrome | 1 | 1998 | 1 | 0.010 |
Why?
|
| Protein Sorting Signals | 1 | 1998 | 2 | 0.010 |
Why?
|
| Cell Compartmentation | 1 | 1998 | 5 | 0.010 |
Why?
|
| Hydrogen Peroxide | 1 | 1998 | 21 | 0.010 |
Why?
|
| 2',3'-Cyclic-Nucleotide Phosphodiesterases | 1 | 1997 | 1 | 0.010 |
Why?
|
| Drug Combinations | 1 | 1997 | 17 | 0.010 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 1995 | 6 | 0.010 |
Why?
|
| Kinetics | 1 | 1995 | 110 | 0.010 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 1991 | 2 | 0.010 |
Why?
|
| Drug Resistance | 1 | 1991 | 20 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 1 | 1991 | 39 | 0.010 |
Why?
|